Mechanism of inhibition of mouse Slo3 (KCa5.1) potassium channels by quinine, quinidine, and barium. by Wrighton, DC et al.
RESEARCH PAPER
Mechanism of inhibition
of mouse Slo3 (KCa5.1)
potassium channels by
quinine, quinidine
and barium
David C Wrighton*, Stephen P Muench and Jonathan D Lippiat
School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK
Correspondence
Jonathan D Lippiat, School of
Biomedical Sciences, Faculty of
Biological Sciences, University of
Leeds, Leeds LS2 9JT, UK. E-mail:
j.d.lippiat@leeds.ac.uk
----------------------------------------------------------------
*Present address: Campden
Instruments, Loughborough, UK.
----------------------------------------------------------------
Received
3 September 2014
Revised
13 May 2015
Accepted
26 May 2015
BACKGROUND AND PURPOSE
The Slo3 (KCa5.1) channel is a major component of mammalian KSper (sperm potassium conductance) channels and
inhibition of these channels by quinine and barium alters sperm motility. The aim of this investigation was to determine the
mechanism by which these drugs inhibit Slo3 channels.
EXPERIMENTAL APPROACH
Mouse (m) Slo3 (KCa5.1) channels or mutant forms were expressed in Xenopus oocytes and currents recorded with 2-electrode
voltage-clamp. Gain-of-function mSlo3 mutations were used to explore the state-dependence of the inhibition. The
interaction between quinidine and mSlo3 channels was modelled by in silico docking.
KEY RESULTS
Several drugs known to block KSper also affected mSlo3 channels with similar levels of inhibition. The inhibition induced by
extracellular barium was prevented by increasing the extracellular potassium concentration. R196Q and F304Y mutations in
the mSlo3 voltage sensor and pore, respectively, both increased channel activity. The F304Y mutation did not alter the effects
of barium, but increased the potency of inhibition by both quinine and quinidine approximately 10-fold; this effect was not
observed with the R196Q mutation.
CONCLUSIONS AND IMPLICATIONS
Block of mSlo3 channels by quinine, quinidine and barium is not state-dependent. Barium inhibits mSlo3 outside the cell by
interacting with the selectivity filter, whereas quinine and quinidine act from the inside, by binding in a hydrophobic pocket
formed by the S6 segment of each subunit. Furthermore, we propose that the Slo3 channel activation gate lies deep within
the pore between F304 in the S6 segment and the selectivity filter.
Abbreviations
KSper, sperm potassium conductance; mSlo3, mouse Slo3 (KCa5.1) channel; WT, wild type
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Introduction
A number of substances, including Ba2+ and quinine, affect
spermatozoa motility and cell volume regulation by inhibit-
ing K+ channels (Yeung and Cooper, 2001; Yeung et al., 2003;
Barfield et al., 2005a,b). Slo3 (KCa5.1) is a strong candidate for
the predominant K+ channel in spermatozoa membranes,
KSper (sperm potassium conductance) (Navarro et al., 2007;
Santi et al., 2010; Zeng et al., 2011; 2013; Brenker et al., 2014;
Mansell et al., 2014). It is also the closest molecular relative of
the large-conductance Ca2+-activated K+ channel Slo1 (BKCa,
maxi-K, KCa1.1), and is strongly expressed in testes (Schreiber
et al., 1998). The mouse (m) Slo3 (KCa5.1) channel is activated
by increased cytosolic pH and not by intracellular Ca2+
(Schreiber et al., 1998; Zhang et al., 2006). In mouse sperma-
tozoa, a Na+-dependent Cl−/HCO3− exchanger is responsible
for intracellular alkalinization during capacitation (Zeng
et al., 1996), which is thought to activate KSper and hyper-
polarize the cell membrane to more negative potentials. This
could increase the driving force for Ca2+ influx through
CatSper channels, thereby increasing sperm motility
(Navarro et al., 2007), although an indirect link between Slo3
and CatSper function involving H+ transporters has also been
proposed (Chavez et al., 2014). Male mice deficient in Slo3 K+
channel subunits (Kcnu1 knockout) are infertile and have
reduced alkalinization-induced K+ conductance (Santi et al.,
2010; Zeng et al., 2011; 2013). In contrast, human spermato-
zoa undergo cytoplasmic alkalinization during capacitation
as a result of proton transport by human voltage-gated
proton channel activity (Lishko et al., 2010). Interestingly,
the human Slo3 (KCa5.1) channel has recently been shown to
be activated by Ca2+ and less reliant on alkalinization, but still
a critical component of KSper channels (Brenker et al., 2014).
Given its importance in sperm physiology, human mutations
in the gene encoding Slo3, KCNU1, are likely to be linked to
male fertility. Hence, sperm ion channels are promising
targets for drugs that either suppress or enhance male fertility
(Lishko et al., 2012).
Despite the technical difficulties in recording KSper cur-
rents from spermatozoa and the poor heterologous expres-
sion of mSlo3 subunits, some of their functional and
pharmacological properties have been correlated. Both KSper
and mSlo3 are blocked by Ba2+, exhibit weak sensitivity to
TEA+ relative to other K+ channels (Schreiber et al., 1998;
Navarro et al., 2007; Martinez-Lopez et al., 2009), are
enhanced by PKA (Martinez-Lopez et al., 2009), and inhibited
by depletion of phosphatidylinositol 4,5-bisphosphate (Tang
et al., 2010a). Native KSper channels are also inhibited by
quinine, clofilium, mibefridil and 5-(N-ethyl-N-isopropyl)-
amiloride (Navarro et al., 2007). Detailed aspects of the phar-
macology of Slo3 channels, including their block by
4-aminopyridine and quinidine, have been investigated by
generating and expressing an mSlo3 chimera, MC13, which
incorporates transmembrane regions from Slo1 (KCa1.1) chan-
nels to improve expression in Xenopus oocytes (Tang et al.,
2010b).
The aim of this study was to investigate the effects of
inhibitors on full-length mSlo3 channels expressed in
Xenopus oocytes. We were particularly interested in the state
dependence of block by quinine, quinidine and Ba2+, and in
comparing their effects on those reported with native KSper
and the MC13 Slo1/Slo3 chimera (Navarro et al., 2007; Tang
et al., 2010b). To explore state dependence, we generated
gain-of-function mutants based on mutations previously
shown to increase the open probability of Slo1 channels:
R196Q is equivalent to an S4 mutation that enhances voltage
activation (Diaz et al., 1998), whereas F304Y is analogous to a
pore mutation that directly increases open probability
(Lippiat et al., 2000). We found that channel inhibition by
these substances was not dependent on channel activity;
however, the binding site for quinine and quinidine was
affected by the F304Y mutation in the mSlo3 pore.
Methods
Molecular biology and oocyte injection
A plasmid containing the full-length mSlo3 sequence was a
gift from Dr L. Salkoff (Washington University School of
Medicine) and the open-reading frame was subcloned into
pBF (Baukrowitz et al., 1999), a vector optimized for in vitro
mRNA synthesis and Xenopus oocyte expression. This ion
channel subunit also has the designation KCa5.1 (Alexander
et al., 2013), but is termed mSlo3 in this paper. The R196Q
and F304Y mutations were introduced by Quikchange site-
directed mutagenesis (Agilent Technologies, Stockport, UK)
and confirmed by automated sequencing. In vitro transcrip-
tion was carried out using the mMessage mMachine SP6 kit
(Ambion, Huntingdon, UK) to produce capped mRNA. Indi-
vidual oocytes were obtained from humanely killed female
Xenopus laevis toads (housed either at the University of Leeds,
UK or from the European Xenopus Resource Centre, Univer-
sity of Portsmouth, UK) and were injected with 10–50 ng
RNA in a 40 nL volume. Oocytes were incubated for at least 2
days at 18oC in a modified Barth’s solution comprising, in
mM, 84 NaCl, 1 KCl, 2.4 NaHCO3, 0.82 MgSO4, 0.41 CaCl2,
Tables of Links
TARGETS
KCa1.1 (Slo1; BKCa)
KCa5.1 (Slo3)
LIGANDS
Ba2+ (BaCl) Mibefradil Quinidine
Clofilium TEA+ Quinine
These Tables list key protein targets and ligands in this article which are hyperlinked to corresponding entries in http://
www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Pawson et al., 2014) and are
permanently archived in the Concise Guide to PHARMACOLOGY 2013/14 (Alexander et al., 2013).
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0.33 Ca(NO3)2, 5 HEPES, adjusted to pH 7.4 with NaOH and
supplemented with 100 IU·mL−1 penicillin/streptomycin,
2 mM pyruvate and 50 mg·mL−1 gentamycin. For oocytes
injected with mutant Slo3 mRNA, survival was improved by
raising the KCl concentration of the Barth’s solution to
23 mM. This brought the resting membrane potential, esti-
mated from the Goldman–Hodgkin–Katz equation, reported
oocyte intracellular ion concentrations (Costa et al., 1989),
and an increased K+ conductance, closer to −30 mV and
within the range of that of a non-injected oocyte.
Electrophysiology
Microelectrodes were pulled from GC100F borosilicate glass
capillaries (Harvard Apparatus, Cambridge, UK) and had
resistances of between 0.3 and 5 MΩ when filled with 3 M
KCl. Oocytes were voltage-clamped by an Axon GeneClamp
500 amplifier (Molecular Devices, Sunnydale, CA, USA) and
currents were digitized with a NI USB-6211 interface
(National Instruments, Newbury, UK) and recorded using
WinWCP v4.0.5 (Strathclyde Electrophysiology Software,
University of Strathclyde, UK). To generate current–voltage
relationships, oocytes were held at −80 mV and pulses from
−100 to +140 mV were applied at 0.2 Hz. For studies of drug
block, pulses were applied to +100 mV followed by a 1.5 s
voltage ramp from −100 mV to +100 mV. Oocytes were per-
fused at room temperature (20–22°C) with a Ringer’s solution
containing, in mM, 115 NaCl, 2.5 KCl, 10 HEPES, 1.8 CaCl2,
pH 8 with NaOH. The volume of the bath was 0.5 mL, which
was perfused at a rate of approximately 1 mL·min−1. 100 mM
K+ solution was made by an equimolar replacement of NaCl
with KCl.
Homology modelling and drug docking
Two homology models for the mSlo3 transmembrane
domains were generated using PHYRE2 (Kelley and Sternberg,
2009) and SWISS-MODEL (Arnold et al., 2006), using the coor-
dinates of a prokaryotic cyclic nucleotide-gated K+ channel
(PDB : 3BEH) as a template, and the tetrameric structural
models were created by fitting the individual subunits into the
tetrameric crystal structure (Clayton et al., 2008) using Deep-
View (Swiss Institute of Bioinformatics, Lausanne, Switzer-
land). The binding of quinidine to mSlo3 homology models
was studied in silico with SwissDock (Grosdidier et al., 2011).
Electrostatic calculations were performed by pdb2pqr
(Dolinsky et al., 2004). Molecular models were visualized and
presented using PyMol (Schrödinger LLC, NewYork, NY, USA).
Materials
All chemicals were reagent grade and obtained from Sigma-
Aldrich (Poole, UK), unless stated otherwise. Quinine (Acros
Organics, Loughborough, UK), quinidine, mibefradil, clo-
filium, barium chloride and tetraethlyammonium chloride
were dissolved in either DMSO or Ringers solution to gener-
ate stock solutions, and then diluted to the required concen-
trations in Ringers solution.
Data analysis and statistical procedures
Data were analysed with WinWCP, OriginPro 7.5 (Originlab,
Northampton, MA, USA), and GraphPad Prism 6 software
(GraphPad Software, San Diego, CA, USA). For drug inhibi-
tion analysis, drug-containing solutions were perfused until
there was no further change in current amplitudes (typically
3–5 min), which were measured towards the end of depolar-
izing steps to +100 mV. Current (I)-inhibition plots were
fitted with the equation: I = (I0 − C)/(1 + ([B]/IC50)nH) + C
where I0 is the current in the absence of inhibitor, [B] the
inhibitor concentration, IC50 the concentration that achieves
half-maximal inhibition, nH the Hill coefficient, and C the
drug-insensitive component of the current. To measure the
voltage dependence of current inhibition by quinine, quini-
dine and Ba2+, current amplitudes evoked by a voltage ramp
were measured at sections corresponding to different volt-
ages. The IC50–voltage relationships were fitted with the
Woodhull equation in the form ln(IC50) = ln(IC500).e−δzVF/RT,
where IC500 is the apparent IC50 at 0 mV, δ the fraction of the
voltage field sensed by the blocking ion, z is the valence of
the blocking ion (+1 for quinine and quinidine, and +2 for
Ba2+), and F, R and T have their standard thermodynamic
meanings. Data are presented as the mean ± SEM of n indi-
vidual oocytes and statistical significance tested using Stu-
dent’s t-test, ANOVA (with Bonferroni post hoc comparison of
means), or by Kruskal–Wallis test (with Dunn’s post hoc com-
parison) as indicated in the Results.
Results
Expression of wild-type (WT) and mutant
mSlo3 channels
Full-length WT, R196Q and F304Y mSlo3 K+ channel subunits
were expressed in Xenopus oocytes and currents recorded by
two-electrode voltage clamp. Oocytes injected with WT
mSlo3 gave rise to outwardly rectifying currents, which were
absent in non-injected oocytes in the 0–100 mV range
(Figure 1A and B). Oocytes injected with mRNA encoding the
mSlo3 mutants R196Q and F304Y also yielded large out-
wardly rectifying currents, but exhibited channel activity at
voltages below the threshold for WT mSlo3 activation
(Figure 1A and B). Expressing R196Q and F304Y mSlo3
resulted in a significantly more negative oocyte resting mem-
brane potential (Figure 1C) compared with control oocytes or
those expressing WT mSlo3. We observed a reduction in the
survival of oocytes expressing the gain-of-function mutants
in normal Barth’s medium, which was rectified by raising the
K+ concentration (see Methods).
Effects of KSper inhibitors on WT
mSlo3 channels
We next studied the effects of drugs that have previously been
shown to inhibit the sperm KSper channel (Navarro et al.,
2007) on WT mSlo3 currents. Like Ksper (Navarro et al.,
2007), Slo3 was weakly inhibited by 5 μM mibefridil and
20 mM TEA+, but more strongly inhibited by 500 μM quinine
and 50 μM clofilium (Figure 2). WT mSlo3 was also strongly
inhibited by 2 mM Ba2+, an effect that was prevented by
raising the extracellular K+ concentration to 100 mM
(Figure 2). The inhibition by each drug was reversible,
although we observed that the amplitude of the current after
washing out mibefridil was often larger than the control
currents.
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Block by quinine and quinidine
We studied the effects of quinine and quinidine in more
detail. Quinine inhibited WT mSlo3 currents evoked by
voltage pulses to +100 mV with an IC50 of 169 ± 40 μM and
Hill slope of 1.0 ± 0.21 (n = 12; Figure 3A and C). F304Y mSlo3
was also blocked by quinine, but with a significantly lower
IC50 of 15.9 ± 3.31 μM (n = 16, P < 0.0005; Hill slope of 0.69
± 0.02). Potency was not significantly altered with the R196Q
mSlo3 mutant, which was blocked by quinine with an IC50 of
166 ± 27.5 μM and Hill slope of 1.3 ± 0.04 (n = 4). The effects
of quinidine, a stereoisomer of quinine, have previously been
studied on the MC13 Slo1/Slo3 chimera (Tang et al., 2010b).
Quinidine blocked WT mSlo3 channels with an IC50 of 19.9 ±
1.41 μM and Hill slope of 1.15 ± 0.15 (n = 7; Figure 3B and D).
Again, the potency of inhibition by quinidine was higher for
F304Y mSlo3 (IC50 of 2.42 ± 0.60 μM, n = 9, P < 0.005, ANOVA;
Hill slope of 0.98 ± 0.12), but lower with R196Q mSlo3 (IC50
of 38.4 ± 6.77 μM, n = 5, P < 0.001, ANOVA; Hill slope of 1.05 ±
0.16). The inhibition of F304Y mSlo by quinidine was
observed to have some time dependence (Figure 3B). To gain
an insight into the mechanisms by which quinine and qui-
nidine block WT and F304Y mSlo3 channels with altered
potencies, we estimated the voltage dependence of the IC50 at
different voltages. Exemplar currents evoked by voltage
ramps and inhibition by quinidine are shown in Supporting
Figure 1
Expression of WT, R196Q and F304Y mSlo3 K+ channels in Xenopus
oocytes. (A) Representative current families recorded by two elec-
trode voltage clamp from oocytes injected with different mSlo3 RNA
or with no RNA (control) as indicated. Oocytes were held at −80 mV
and 100 ms pulses to potentials between −100 and +140 mV were
applied. The dashed line represents the zero-current levels and scale
bars represent equivalent current amplitudes and timescales. (B)
Mean (± SEM) current–voltage relationships of oocytes expressing
WT mSlo3 (WT, n = 29), R196Q mSlo3 (n = 8) F304Y mSlo3 (n = 26),
and non-injected oocytes (control, n = 12). For symbols used see part
(A). (C) Mean (± SEM) resting membrane potential of oocytes in
standard Ringer’s solution. *P < 0.0001 compared with control
oocytes (Kruskal–Wallis test).
Figure 2
Block of mSlo3 currents by inhibitors of KSper. Oocytes were held at
−80 mV and depolarizing pulses to +100 mV were applied. (A) Rep-
resentative traces with each drug or condition as indicated: black
trace, control currents recorded prior to drug application; light grey
trace, current in the presence of the inhibitor; dark grey trace,
current after washing out the inhibitor for at least 10 min. The
dashed line represents the zero-current level and scale bars represent
equivalent current amplitudes and timescales. The effects of Ba2+
were measured in both the standard solution containing 2.5 mM K+
(2.5K) and with a high 100 mM K+ solution (100K). (B) Mean per-
centage inhibition for each drug or condition as indicated (n values
indicated in parentheses in the bars).
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Information Figure S2. We found that the F304Y mutation
significantly increased the electrical distance, δ, sensed by the
blockers from −0.12 ± 0.07 (n = 12) to −0.49 ± 0.22 (n = 12,
P < 0.01) for block by quinine (Figure 3E), and from −0.12 ±
0.40 (n = 7) to −0.46 ± 0.15 (n = 9, P < 0.05) for block by
quinidine (Figure 3F; two-way ANOVA). The negative values for
the electrical distance, δ, represent a positively charged mol-
ecule moving into the pore from the intracellular face of the
channel.
Inhibition by Ba2+ ions
To determine if the F304Y mutation had more wide-ranging
effects on the structure of the pore we studied inhibition by
Ba2+ ions. Concentration–inhibition curves were generated
for both WT and F304Y mSlo3 currents evoked by depolariz-
ing steps to +100 mV. Despite the differences in channel
activity, the properties of inhibition by Ba2+ were similar. The
IC50 was 646 ± 100 μM (n = 6) and 525 ± 97 μM (n = 5), with
Hill slopes of 0.88 ± 0.11 and 1.05 ± 0.12 for WT and F304Y
mSlo3 respectively (Figure 4A and B). Inhibiting concentra-
tions of Ba2+ also appeared to slow the activation of the
currents upon depolarization (Figure 4A). Voltage depend-
ence of Ba2+ inhibition was estimated by measuring the appar-
ent IC50 at different voltages, as before. Inhibition of WT and
F304Y mSlo3 by Ba2+ was not significantly different with δ
values of 0.20 ± 0.09 and 0.12 ± 0.05 respectively (Figure 4C).
Figure 3
Concentration-dependent inhibition of WT, F304Y and R196Q mSlo3 currents by quinine and quinidine. Representative traces recorded before
(0) and in the presence of quinine (A) and quinidine (B) (concentrations in μM as indicated). The dashed line represents the zero-current levels
and scale bars represent equivalent current amplitudes and timescales. Mean (± SEM) concentration–inhibition plots for quinine (C) and quinidine
(D) inhibition of WT mSlo3, R196Q mSlo3 and F304Y mSlo3 at +100 mV, fitted by the Hill equation provided in the Methods. Apparent
voltage-dependence of the IC50 for quinine (E) and quinidine (F) of WT and F304Y mSlo3 currents. The data are described and analysed further
in the main text. For key to symbols used see Figure 1.
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Structural model of mSlo3 and inhibition
by quinidine
Both Phyre2 and SWISS-MODEL produced homology models
of the mSlo3 transmembrane domain, which were highly
similar to each other showing a root mean square deviation
of 0.43 Å, giving confidence to the resulting model. Models
based on the bacterial cyclic nucleotide-regulated ion
channel (PDB: 3BEH) or other K+ channel structures showed a
common architecture. Docking of quinidine by SwissDock
produced a number of predicted mSlo3 binding sites. Most
sites were located in the periphery of the K+ channel protein
at the protein-lipid interface, likely due to the hydrophobic
nature of quinidine and, due to the distance from the pore,
therefore false-positive results. However, SwissDock also pre-
dicted a quinidine-binding site, which involved pore-lining
residues F304, I308 and V312. Analysis of the model shows
how quinidine is accommodated within a hydrophobic
pocket, complementing the hydrophobic character of the
inhibitor. Moreover, the replacement of F304 by tyrosine
results in the phenolic group being sufficiently close to
potentially form a hydrogen bond to the nitrogen on the
methoxyquinoline group of quinidine (Figure 5C), which
might improve the efficacy of quinidine binding to F304Y
mSlo3. Interestingly, SwissDock did not identify any binding
sites within the pore for quinidine when F304 was changed to
Y304 in the homology model. This may be caused by the
bulkier nature of the tyrosine side chain not accommodating
the bound inhibitor, since binding site plasticity and side-
chain movement is not accounted for in SwissDock.
Discussion
We investigated the characteristics of mSlo3 channel inhibi-
tion by known blockers by generating mutations that alter
open probability. The observation that the R196Q and F304Y
mutations both resulted in increased channel activity, par-
ticularly at more negative voltages, demonstrates a close
structure–function relationship with Slo1 (BKCa, KCa1.1) subu-
Figure 4
Concentration-dependent inhibition of WT and F304Y mSlo3 cur-
rents by Ba2+. (A) Representative traces recorded before (0) and in the
presence of Ba2+ (concentrations in mM as indicated). The dashed
line represents the zero-current levels and scale bars represent
equivalent current amplitudes and timescales. (B) Mean (± SEM)
concentration inhibition plots for WT and F304Y mSlo3 at +100 mV,
fitted by the Hill equation provided in the Methods. (C) Apparent
voltage-dependence of the IC50 for block by Ba2+ of WT and F304Y
mSlo3-mediated currents. The data are described and analysed
further in the main text. For key to symbols used see Figure 1.
Figure 5
Molecular modelling of mSlo3 and inhibition by quinidine. (A)
Homology model of the transmembrane regions S1 to S6 of mSlo3;
the structure is shown as a side-on view from the membrane, with
the extracellular space above the protein. Each subunit of the tetra-
meric structure is coloured differently for clarity and only side chains
F304, I308 and V312 are shown in stick format. (B) A zoomed-in view
of the proposed quinidine-binding site, with subunits labelled blue,
red and green, (the fourth subunit has been removed for clarity). The
residues which make up the hydrophobic binding pocket (F304, I308
and V312) are shown in stick format and the surface shows the
hydrophobic isoelectric character. (C) The same view as in (B) but
with tyrosine replacing F304, showing the proximity of the terminal
oxygen to the methoxyquinoline group of quinidine where hydro-
gen bonding could occur. In both (B) and (C), the quinidine mol-
ecule is shown in stick format and coloured, yellow, blue and red for
carbon, nitrogen and oxygen respectively. (D) Proposed mechanisms
for the inhibition induced by Ba2+ ions and quinine or quinidine
(Qn/Qd): Ba2+ enters the pore from the extracellular side and blocks
at the selectivity filter; quinine and quinidine cross the membrane
and block from the intracellular side at a site involving F304 and I308
(left). In the F304Y mutation (right), the Ba2+ block is unaffected, but
a deeper binding site is available for quinine and quinidine entering
the pore from the intracellular side. Possible mechanisms are dis-
cussed in the main text.
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nits. The hyperpolarized membrane potentials with R196Q
and F304Y mSlo3 expression demonstrate that the K+ selec-
tivity of the channel, previously thought to be weak
(Schreiber et al., 1998), is sufficient to hyperpolarize the
membrane to strongly negative potentials when channels are
activated. Increased activity at negative potentials in vivo is
thought to be brought about by co-expression with accessory
proteins; candidate accessory proteins are Sloβ4 (Yang et al.,
2009) and LRRC52 (Yang et al., 2011; Zeng et al., 2015). We
found that the mSlo3 channel has a pharmacological profile
similar to that of native mouse KSper channels (Navarro et al.,
2007) providing further support that mSlo3 underlies, at least
in part, this current.
The results with quinine and quinidine indicate that they
both block the channel by the same mechanism and site,
although with slightly different potency. Quinidine inhibited
WT mSlo3 at +100 mV with similar concentrations as those
described with the Slo1/Slo3 chimera containing the mSlo3
pore (Tang et al., 2010b). The voltage-dependence of inhibi-
tion by quinidine was also found to be weak, although no
inhibitory effect was observed with voltages more positive
than those used in the present study (Tang et al., 2010b). The
negative slopes that we obtained from the Woodhull plots
with block by quinine and quinidine indicate that the drugs
enter the mSlo3 channel pore from the intracellular side,
presumably by traversing the membrane in the unprotonated
state. The efficiency of protonation of the drugs in the cyto-
plasm, which may be affected by the pH buffering of the
oocyte, may contribute to the variability in IC50 values. None-
theless, an interesting effect of the F304Y mSlo3 mutation
was its increased sensitivity to inhibition by both quinidine
and quinidine compared to WT mSlo3. This observation was
initially thought to be as a result of open channel blockade,
where the increased open probability of the channels
increased the apparent sensitivity to inhibition. However, the
results of further experiments provided a better explanation
for this observation. Firstly, the F304Y mutation increased the
voltage- dependence of block by quinine and quinidine, sug-
gesting that these drugs are able to bind deeper into the
F304Y mSlo3 pore. Increased sensitivity to either quinine or
quinidine was not observed with the large gain-of-function
produced by the R196Q mutation, which rules out increased
open probability of this channel as the cause of this effect.
The F304Y mutation resulted in a novel binding site where
quinine and quinidine were able to block mSlo3 with greater
potency than WT mSlo3 channels. The time-dependence of
the inhibition of F304 mSlo3 by quinidine may reflect the
movement of the drug into the pore induced by the strong
depolarization, although an interaction close to the gate at
this deeper site cannot be ruled out. The results from the
molecular modelling indicate the possibility that this muta-
tion allows an additional hydrogen bond between the tyros-
ine (Y304) to the methoxyquinoline group of quinidine,
which would increase the affinity of the channel pore to
quinine or quinidine. An alternative explanation is that the
F304Y mutation results in a conformational position of the
S6 helix that reveals a higher affinity binding site deeper in
the pore. Interestingly, the effect of this mutation is comple-
mented by the findings with HERG (human ether-a-go-go
related gene) K+ channels, where a structurally analogous, but
reverse mutation, Y652F, suppressed the voltage-dependent
block by quinidine (Sanchez-Chapula et al., 2003). Our
molecular models can be further refined through further
structural and pharmacological analysis.
The alleviation of the Ba2+-induced block of WT mSlo3
observed on raising the extracellular K+ concentration is con-
sistent with increased occupancy by K+ at a site in the pore
analogous to the Slo1 (BKCa} ‘external lock-in’, which pre-
vents Ba2+ from entering the pore and binding at a deeper site.
The relative locations of K+ and Ba2+ ions in a K+-selective pore
have also been demonstrated crystallographically with the
Kcsa channel (Jiang and MacKinnon, 2000), and we propose
that these corresponding cation binding sites exist in mSlo3.
Extracellular K+ concentration is therefore a major factor
affecting potency of block by extracellular Ba2+. Furthermore,
the similar results obtained from studies of Ba2+ blockade of
WT and F304Y mSlo3 demonstrate that this mutation did not
affect the selectivity filter. Ba2+ blocked both WT and F304Y
mSlo3 with similar potency and voltage-dependence and the
positive slope of the Woodhull plot reinforces the idea that
externally applied Ba2+ enters the pore from outside of the
cell. The slower current activation in the presence of Ba2+ is
consistent with the block being alleviated upon depolariza-
tion and further supports the idea that this ion can block the
channel whilst it is closed. The negative resting membrane
potentials that were obtained by expressing either R196Q or
F304Y mSlo3 indicate that the latter mutation had no appre-
ciable effect on the ionic selectivity of the mSlo3 pore.
Finally, our results suggest that the location of the activa-
tion gate in Slo3 channels may be similar to that of the closely
related Slo1 (BKCa) channel. We conclude that inhibition of
mSlo3 by bariumandquinine/quinidine are not dependent on
the channel being in the open or closed state. This indicates
that the activation gate lies between the Ba2+ and quinine/
quinidine-binding sites in WTmSlo3. Structurally, this points
to a region deep within the pore between the selectivity filter
and F304, and not at an S6 helix bundle at the intracellular
face. This idea corresponds well with the conclusions of pre-
vious studies on BKCa channels in that an S6 helix bundle is
unlikely to form a gate to permeating ions (Wilkens and
Aldrich, 2006; Zhou et al., 2011), and that gating may involve
side-chain reorientation of S6 residues deep within the pore
and close to the selectivity filter (Chen et al., 2014).
To conclude, the extracellular K+ concentration negatively
influences the potency of Ba2+ in blocking Slo3 K+ channels,
and probably, therefore, KSper. We propose that quinine and
quinidine inhibit Slo3 channels by binding to hydrophobic
side chains found at the intracellular region of the channel
pore. We also described two mutations in mSlo3 that
increased channel activity and demonstrate a close structure–
function relationship to Slo1 (BKCa; KCa1.1) channels. It is
expected that pharmacological modulation of Slo3 K+ chan-
nels will affect the function of spermatozoa and this ion
channel presents a novel therapeutic target in the treatment
or control of male fertility.
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Figure S1 A–C. Currents recorded from oocytes expressing
WT and mutant mSlo3 as indicated following perfusion of
bath solution containing 98 mM KCl and no sodium. The
holding potential was −80 mV and pulses were applied in
10 mV steps to up to +140 mV. The scale bars apply to each
panel and the zero-current levels are indicated by the dashed
lines. Mean ± SEM. (n = 5 or 6) current- (D) and conductance-
voltage (E) relationships from oocytes expressing WT (●),
F304Y (▲) and R196Q (▼) mSlo3. F Relationship between
reversal potentials measured and bathing [K+], where [Na+] =
98 mM − [K+].
Figure S2 Block by quinidine of currents evoked by a voltage
ramp protocol from oocytes expressing WT (A), F304Y (B),
and R196Q (C) mSlo3. (D) The time-course of the voltage
ramp. The concentration of quinidine, in μM, is shown to the
right of the current trace, with 0 the control current prior to
perfusing quinidine.
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